Michelle Gilson


Oppenheimer Bullish on Sarepta Therapeutics Inc (SRPT) Following Dr. Farkas’ FDA Departure

Sarepta Therapeutics Inc (NASDAQ:SRPT) shares shot up nearly 13% today in the wake of Dr. Ronald Farkas, arguably the most oppositional team leader …

Oppenheimer Remains Positive on Sarepta Therapeutics Inc (SRPT) in Wake of Santhera FDA Rejection

Analyst Michelle Gilson of Oppenheimer feels confident about eteplirsen, a pipeline drug for Sarepta Therapeutics Inc (NASDAQ:SRPT), even though Santhera, a competitor of …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts